Premium
Gardasil: first vaccine for human papillomavirus infection
Author(s) -
Chaplin Steve,
Szarewski Anne
Publication year - 2007
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.107
Subject(s) - gardasil , genital warts , medicine , cervical cancer , human papillomavirus , dysplasia , human papillomavirus vaccine , virology , dermatology , gynecology , cancer
Abstract Gardasil is a quadrivalent human papillomavirus vaccine for the prevention of cervical cancer, cervical and vulvar dysplasia and external genital warts. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and Dr Anne Szarewski comments on the implications of the proposed immunisation programme. Copyright © 2007 Wiley Interface Ltd